Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and stretching both needed for nipple area skin growth in mice.

Human scalp hair follicles can produce and respond to several hormones, affecting hair growth and pigmentation.

Psychological stress and personal history are significant factors in hair loss.

Estrogen is important for keeping adult mouse nipple skin healthy by controlling certain cell signals.

The document concludes that the hCG protocol may help in obesity treatment and could be scientifically justified, but more research is needed.

Prolactin affects the production of different keratins in human hair, which could lead to new treatments for skin and hair disorders.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Monkeys with hair loss during pregnancy showed higher stress hormone levels and invested differently in their offspring.

A woman with Sheehan syndrome improved with hormone treatment.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Androgens, male hormones, play a role in both men and women's health, and testosterone therapy can help women with low levels, but it's not suitable for pregnant or lactating women, or those with certain conditions.

Field bean supplementation improved mohair growth and kid growth in Angora goats but didn't prevent weight loss after giving birth.

Ficus carica extract improved fertility in rats and may help with certain health conditions.

Stress-related hair loss was reversed with a special medication.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Parathyroid hormone-related protein helps control hair growth phases in mice.

Hormones and genes affect hair growth and male baldness.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Reproductive hormones play a crucial role in breast cancer development and treatment challenges.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.